KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
International health agencies, including the World Health Organization, have stepped in to support local medical teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo has launched an Ebola vaccination campaign as health responders intensify ring-vaccination approaches around identified infection clusters to halt the spread of the virus.
Priority for Ervebo Vaccines Allocated to Healthcare Professionals in Kisangani
Operational challenges in logistics persist due to complex regional infrastructure, ongoing security issues, and high mobility across border districts. Kisangani has established cold-chain supply networks to keep vaccines at the necessary ultra-low temperatures before delivery to remote health zones. The Ebola vaccination effort is underway as civil defense and community health workers carry out educational campaigns aimed at strengthening disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working closely with local teams to track adverse events and assess immune responses among vaccinated populations. Officials highlighted that early clinical detection, combined with isolation and supportive care, remains vital for improving survival rates. Additional vaccine shipments are expected as distribution expands to additional health districts regionally.
Strict Infection Control Measures Enforced in Treatment Facilities by Health Authorities
National response teams continue expanding contact tracing operations across urban and rural zones in the eastern regions. Local health centers are supplied with personal protective equipment, diagnostic reagents, and treatment supplies to bolster preparedness. The government reaffirmed that comprehensive public health protocols will stay in place until viral transmission metrics show sustained decline across all affected provinces.
The government has called on communities to fully cooperate with mobile vaccination teams and to follow established health guidelines. Increasing immunization among high-risk groups is expected to stabilize infection rates over upcoming weeks. Monitoring networks will remain vigilant at transportation hubs and border crossings to prevent further geographic spread.